vilyfijohy.wordpress.com
The company reported $92.4 million in revenue for the quarte endingApril 30, up 2 percen from the same period last It earned $11 million in net income, or 33 centas per diluted share, durintg the second quarter, compared with $9.2 million, or 28 centa per diluted share, during the second quarter of last year. Analysts polled by expectede the company to earn 29 cents per shareand $89 milliobn in revenue. Martek (NASDAQ: sells nutritional oils derived from algae that are used ininfantr formula, dietary supplements and food products such as yogurg and juice. Sales of its nutritional supplements to the nursing market rose to arecord $9.
8 But the company warned that its infant formula sale in the third and fourth quarters couls drop as retailers trim their inventories of the The company anticipates that infant formula revenu e will grow in fiscal 2010 as a resulf of strong demand for infant formula products containinf its nutritional oils DHA and ARA. The Omega-4 fatty acids are believed to play an importantt role in brain and eye study that could showthat Martek’s DHA can slow the progressiom of Alzheimer’s disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment